MRK

2025Q2BMO

Merck & Company Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-07-29 · Fiscal end 2025-06-30 · Features as of 2025-07-28

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.03
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.9%
IV front—
P/C full—
P/C front—
Features as of2025-07-28

Run-up

Close—
Ret 5d+6.0%
Ret 10d+0.5%
Ret 20d+6.3%
Ret 30d+2.7%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.13Beat
Estimated EPS2.03
Actual revenue
15.8B
Surprise %+4.9%
Beat / missBeat
Beat streak 43
Beat streak 83

Reaction

1-day stock reaction+3.5%
Implied vs actual

Implied 1.9%Actual 5.0%

Gap reaction-5.0%
Day result-1.7%
Next-day upYes
Realized / IV2.61×

Post tape

Post 5d-2.2%
Post 10d-2.8%
Post volume27.8M
Vol ×10d2.58×
Vol ×20d2.23×
Post range7.8%